Vaxart, Inc.
385 Oyster Point #9A
South San Francisco
California
94080
United States
Website: http://www.vaxart.com/
121 articles about Vaxart, Inc.
-
Aviragen Therapeutics and Vaxart Enter into Merger Agreement
10/30/2017
The merger will result in a combined company, Vaxart, focused on developing orally-delivered therapeutics and prophylactics to address a variety of viral infections.
-
Vaxart Announces Positive Topline Results for Its Oral Tablet Vaccine in Phase II Influenza Challenge Study
10/26/2017
Vaxart announced today that its H1 influenza oral tablet vaccine demonstrated similar protection against influenza virus as the market-leading injectable quadrivalent influenza vaccine (QIV) in a clinical trial.
-
Vaxart Announces Positive Phase I Study Of Oral Norovirus Vaccine
2/14/2017
-
Vaxart Challenges Takeda with Oral Norovirus Vaccine
8/8/2016
-
Vaxart Initiates Clinical Development Of First Oral Norovirus Vaccine
8/2/2016
-
Vaxart Initiates Clinical Development Of First Oral RSV Vaccine
6/28/2016
-
Vaxart To Present At Jefferies 2016 Healthcare Conference
6/6/2016
-
Vaxart Pins Hopes on Oral Zika and Flu Virus Vaccines
3/25/2016
-
Vaxart, Inc. Begins Preclinical Testing Of An Oral Zika Virus Vaccine
3/3/2016
-
Vaxart, Inc. Appoints Samir Singh As Senior Vice President, Corporate Development And Strategy
2/9/2016
-
Vaxart, Inc. To Present At Leerink Partners Global Healthcare Conference
2/4/2016
-
Vaxart, Inc. Announces Enrollment Of First Patient In Influenza B Phase I Trial
12/17/2015
-
Vaxart, Inc. Awarded $13.98 Million HHS-BARDA Contract To Support Advanced Development Of Influenza Tablet Vaccine
10/28/2015
-
Vaxart, Inc. To Present Key Data Related To Its Oral Norovirus And Seasonal Influenza Tablet Vaccines At The 9th Vaccine & ISV Congress In Seoul
10/19/2015
-
Vaxart, Inc. To Present Phase I Data At IDWeek 2015 Demonstrating Influenza Tablet Vaccine Induces Dose Dependent T Cell Responses
10/8/2015
-
Vaxart, Inc. To Present Preclinical Data On Oral Quadrivalent Influenza Vaccine At ICAAC/ICC 2015
9/17/2015
-
Vaxart, Inc. Announces Lancet ID Publication Of Influenza Tablet Vaccine Phase 1 Results
8/24/2015
-
Vaxart, Inc. To Present At The 6th Euro Global Summit And Expo On Vaccines And Vaccination In Birmingham, UK On August 18, 2015
8/17/2015
-
Vaxart, Inc. To Present At The Mucosal Immunology Conference In Berlin On July 17, 2015
7/14/2015
-
Vaxart, Inc.To Present At Phacilitate’s VAX 1-2-1 In Amsterdam On May 20, 2015
5/20/2015